| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.002 | 0.9 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |